Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bumcrot

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Nucleic Acids Research|December 6, 2023
JMnorm: a novel joint multi-feature normalization method for integrative and comparative epigenomicsGuanjue Xiang, Yuchun Guo, David Bumcrot, et al.
Nature Chemical Biology|November 17, 2006
RNAi therapeutics: a potential new class of pharmaceutical drugsDavid Bumcrot, Muthiah Manoharan, Victor Koteliansky, et al.
RNA (New York, N.Y.)|December 21, 2013
Tissue-specific gene silencing monitored in circulating RNAAlfica Sehgal, Qingmin Chen, Derrick Gibbings, et al.
Cancer Biology & Therapy|May 24, 2008
MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancerOskar W Rokhlin, Vladimir S Scheinker, Agshin F Taghiyev, et al.
Human Gene Therapy|June 13, 2015
Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene TherapyJennifer L Gori, Patrick D Hsu, Morgan L Maeder, et al.
Plos One|August 17, 2010
Alpha-synuclein suppression by targeted small interfering RNA in the primate substantia nigraAlison L McCormack, Sally K Mak, Jaimie M Henderson, et al.
Cancer Biology & Therapy|March 28, 2007
Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survivalOskar W Rokhlin, Agshin F Taghiyev, K Ulrich Bayer, et al.
Blood|December 11, 2012
An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermediaPaul J Schmidt, Iva Toudjarska, Anoop K Sendamarai, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 11, 2008
Assessing siRNA pharmacodynamics in a luciferase-expressing mouseRobert U Svensson, Michael R Shey, Zuhair K Ballas, et al.
Human Gene Therapy|April 12, 2018
Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic MiceShen Shen, Minerva E Sanchez, Keith Blomenkamp, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Nucleic Acids Research|December 6, 2023
JMnorm: a novel joint multi-feature normalization method for integrative and comparative epigenomicsGuanjue Xiang, Yuchun Guo, David Bumcrot, et al.
Nature Chemical Biology|November 17, 2006
RNAi therapeutics: a potential new class of pharmaceutical drugsDavid Bumcrot, Muthiah Manoharan, Victor Koteliansky, et al.
RNA (New York, N.Y.)|December 21, 2013
Tissue-specific gene silencing monitored in circulating RNAAlfica Sehgal, Qingmin Chen, Derrick Gibbings, et al.
Cancer Biology & Therapy|May 24, 2008
MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancerOskar W Rokhlin, Vladimir S Scheinker, Agshin F Taghiyev, et al.
Human Gene Therapy|June 13, 2015
Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene TherapyJennifer L Gori, Patrick D Hsu, Morgan L Maeder, et al.
Plos One|August 17, 2010
Alpha-synuclein suppression by targeted small interfering RNA in the primate substantia nigraAlison L McCormack, Sally K Mak, Jaimie M Henderson, et al.
Cancer Biology & Therapy|March 28, 2007
Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survivalOskar W Rokhlin, Agshin F Taghiyev, K Ulrich Bayer, et al.
Blood|December 11, 2012
An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermediaPaul J Schmidt, Iva Toudjarska, Anoop K Sendamarai, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 11, 2008
Assessing siRNA pharmacodynamics in a luciferase-expressing mouseRobert U Svensson, Michael R Shey, Zuhair K Ballas, et al.
Human Gene Therapy|April 12, 2018
Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic MiceShen Shen, Minerva E Sanchez, Keith Blomenkamp, et al.
Pageof 3